Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (2037)	8/3/2008 9:40:48 AM
From: Pseudo Biologist	Read Replies (2) \| Respond to of 2240

I would have guessed Abgenix, but you are most likely correct that this used Medarex-Kirin technology instead: patentlens.net "Human anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors" ... Production of Human Monoclonal Antibodies Against Nerve Growth Factor (NGF) Transgenic HuMab and KM Mice Fully human monoclonal antibodies to NGF were prepared using HCo7, HCol2, HCo7+HCol2, and KM strains of transgenic mice, each of which expresses human antibody genes. How did you know that? PB